Martin Shkreli Faces New Accusations Over High-Priced Drug

A lawsuit by the Federal Trade Commission and New York ’s attorney general says his company blocked generic rivals after sharply raising the cost of Daraprim.

Source: NYT Health - January 28, 2020 Category: Consumer Health News Authors: Cecilia Kang Tags: Shkreli, Martin (1983- ) James, Letitia Federal Trade Commission Antitrust Laws and Competition Issues Drugs (Pharmaceuticals) Toxoplasmosis Vyera Pharmaceuticals Source Type: news